MeCP2 Represses Enhancers through Chromosome Topology-Associated DNA Methylation

Adam W. Clemens, Dennis Y. Wu, Russell Moore, Diana L. Christian, Guoyan Zhao, Harrison W. Gabel. Molecular Cell, Volume 77, Issue 2, 16 January 2020, Pages 279-293.e8 Read More

Abstract

The genomes of mammalian neurons contain uniquely high levels of non-CG DNA methylation that can be bound by the Rett syndrome protein, MeCP2, to regulate gene expression. How patterns of non-CG methylation are established in neurons and the mechanism by which this methylation works with MeCP2 to control gene expression is unclear. Here, we find that genes repressed by MeCP2 are often located within megabase-scale regions of high non-CG methylation that correspond with topologically associating domains of chromatin folding. MeCP2 represses enhancers found in these domains that are enriched for non-CG and CG methylation, with the strongest repression occurring for enhancers located within MeCP2-repressed genes. These alterations in enhancer activity provide a mechanism for how MeCP2 disruption in disease can lead to widespread changes in gene expression. Hence, we find that DNA topology can shape non-CG DNA methylation across the genome to dictate MeCP2-mediated enhancer regulation in the brain. © 2019 Elsevier Inc.

Clemens and Wu et al. demonstrate that DNMT3A establishes non-CG DNA methylation across topologically associating domains in neurons, resulting in broad regions of high and low methylation. Within regions of enriched DNA methylation, MeCP2 represses the activity of enhancers, regulating promoter activation for genes controlled by these enhancers. © 2019 Elsevier Inc.

Full Text

.

Posted on January 22, 2020
Posted in: Neurogenetics & Transcriptomics, Publications Authors: